Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Healthcare Biotechnology
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United... see more

Bullboard (TSXV:MPH)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Comment by nozzpackon May 13, 2020 1:30pm

RE:Q1

Holding nicely at cash level. Have liquidated  rest of my shares and bought more Cipher which just came out with blowout numbers . GLTA
146
Discussion
Post by nozzpackon May 12, 2020 6:10pm

Q1

Not great as basically only aggrasat sales. of positive note was that cash burnt was only $270,000 . Another positive is that Zypitamag sales increased from $93,000 in Q4 to $163,000 in Q1. Q1 ...more  
232
Discussion
Post by Checkouton May 12, 2020 3:41pm

i guess s i am wrong insider buy $112,867

Issuer Name Medicure Inc. Insider Name Friesen, Albert David Relationship as filed with regulators 4 - Director of Issuer,5 - Senior Officer of Issuer Transaction ID ...more  
178
Comment by nozzpackon May 12, 2020 2:27pm

RE:First Quarter Expectations

Don't know about $4 m revenue. Main info I seek is the outlook. looks like after hour release
99
Discussion
Post by carrot50on May 11, 2020 3:45pm

First Quarter Expectations

Sales above $4 millon No loses or unexpected BS Guidance for remainer of the year Covid implications to sales - good or bad Updates on trials in the system Sorry about the last post It was supposed ...more  
182
Discussion
Post by Checkouton May 06, 2020 10:12pm

Medicure Q1 2020 results and conference call dates

WINNIPEG, May 6, 2020 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the ...more  
247
Post by carrot50on May 05, 2020 5:33pm

First Quarter

Results should be out soon. Hopefully they aren't too bad. Market seems to think so.
180
Comment by nozzpackon May 01, 2020 9:08am

RE:RE:RE:RE:RE:RE:$1.25 and dropping

The major spring board for catalyst is for Zypitamag sales to show substantial growth potential. Also, if the treatment market for Aggrasat can be expanded whether formally ( results of the two ...more  
176
Discussion
Comment by JCWon Apr 30, 2020 9:59am

RE:RE:RE:RE:RE:$1.25 and dropping

Hopefully, trading below cash will act as a "For Sale" sign!!
107
Discussion
Comment by eSnowdenon Apr 29, 2020 10:08pm

RE:RE:RE:RE:$1.25 and dropping

how does a co. trade at cash or below...simple, there are no revenue catalysts. Aggrastat is highly profitable, however total revenues have declined substatially. Friessen propped up the share price ...more  
179
Discussion
Comment by JCWon Apr 29, 2020 8:43pm

RE:RE:RE:$1.25 and dropping

Well, the risk/reward ratio is pretty good when you're buying shares at less than cash and less than half book value..particularly when you have capital gains to offset ...as plenty do.... The ...more  
140
Discussion
Comment by nozzpackon Apr 29, 2020 5:26pm

RE:RE:$1.25 and dropping

Lots of buyers tho. Trading less than cash and less than half of book. Irrationale selling is part and parcel of these extremely unusual markets. Many investors are forced to sell to cover losses ...more  
122
Discussion
Comment by JCWon Apr 29, 2020 4:19pm

RE:$1.25 and dropping

After a huge fiasco and share writedown prior to 2006, these new shares were at $10 in 2017....just 3 years ago!! Where did all that money go?? Someone is surely accountable and should be identified ...more  
134
Discussion
Post by carrot50on Apr 29, 2020 2:10pm

$1.25 and dropping

Piiss poor management Wasting lots of cash on bad decisions Under a buck by the end of May for sure
178
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities